What they were paid
BeOne Medicines Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $92,500 | $199,834 | $199,954 | $0 | $492,288 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BeOne Medicines Ltd. DEF 14A filed April 28, 2026, accession 0001104659-26-049655, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025BeOne Medicines pays directors a $598,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Commercial and Medical Affairs Advisory
The rest of the BeOne Medicines board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alessandro Riva | Independent Director | $494,788 |
| Anthony C. Hooper | Independent Director | $528,129 |
| Charles L. Sawyers | Independent Director | $0 |
| Corazon (Corsee) D. Sanders | Independent Director | $502,288 |
| Elizabeth F. Mooney | Independent Director | $0 |
| Felix J. Baker | Independent Director | $0 |
| John V. Oyler | Chair of the Board | $0 |
| Margaret Dugan | Independent Director | $514,788 |
| Michael Goller | Independent Director | $484,788 |
| Qingqing Yi | Independent Director | $489,788 |
| Ranjeev Krishana | Independent Director | $489,788 |
| Shalini Sharp | Independent Director | $525,165 |
| Xiaodong Wang | Director | $4,249,830 |
The full BeOne Medicines compensation record
free company briefThis page is one director within BeOne Medicines's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat